Home
News
Weekly
Projects
Topics
Sectors
Substances
Events
Clusters
Search
Product
Pricing
About Us
Sign in
Chemical industry plants and projects, tracked since 2013
Product
Pricing
About Us
Sign in
Home
News
Weekly
Projects
Topics
Sectors
Substances
Events
Clusters
Innovation and Product Development news
23 September 2026
Casale to supply 100 MTD modular green ammonia plant to Neptun in Glomfjord
SMART‑N technology under an EPF contract with modular off‑site fabrication, 10–100% operating range with staged hydrogen rollout and downstream conversion to nitric acid and fertilizers.
23 September 2026
Roche’s sefaxersen reduces proteinuria in phase III IMAgINATION trial
Interim analysis shows significant, clinically meaningful 24‑hour UPCR reduction at 37 weeks; blinded study continues to the eGFR endpoint at week 105.
23 September 2026
BASF launches reduced‑PCF paper coating dispersions for cost‑effective Scope 3.1 reductions
Paper coating binders with ~20–45% lower cradle‑to‑gate PCF offered as drop‑in replacements, produced with low‑PCF raw materials and green utilities to support Purchased Goods & Services (Scope 3.1).
22 September 2026
Genentech's sefaxersen reduces proteinuria in Phase III IgAN interim analysis
Phase III interim data show significant proteinuria reduction at 37 weeks; drug targets liver-derived factor B via monthly subcutaneous dosing; blinded follow-up continues to week 105 eGFR.
22 September 2026
Petrobras uses technical corn oil in asphalt production
Revap has produced 95,000 t of CAP Pro R asphalt using technical corn oil, a semi‑refined residual from corn ethanol processing sourced from Inpasa.
22 September 2026
Amgen: Dazodalibep met Phase 3 primary endpoint in moderate-to-severe Sjögren's disease
Phase 3 trial showed rapid, sustained reduction in systemic disease activity in moderate-to-severe Sjögren's disease with manageable safety signals.
The right choices in the European chemical industry
Save time with
chemXplore
Learn more
22 September 2026
Merck updates WINREVAIR label with Phase 3 HYPERION data for newly diagnosed PAH
FDA updates PAH therapy label to include HYPERION data showing a 76% reduction in clinical worsening when added to background therapy for patients diagnosed within 12 months.
22 September 2026
ORLEN seeks AI partners from large tech firms and R&D specialists
RFP open to AI vendors with generative AI, ML, data science and industrial deployment experience; Polish firms encouraged; details on Connect platform.
22 September 2026
LANXESS at SEPAWA 2026: preservatives, Cosmelin esters and Scopeblue offerings
Shows preservative solutions for pet care, launches biodegradable Cosmelin esters as a silicone alternative, presents Scopeblue lower‑carbon preservatives and an Oct 16 LCA talk.
22 September 2026
Sulzer supplies DEVO purification unit to BeyondPoly's 100,000 t/y POE plant in China
DEVO™ purification unit commissioned and operating at planned capacity in a new 100,000 t/y POE plant; system reduces residual volatiles while using less energy than alternatives.
22 September 2026
Symrise opens Lautier 1795 production site in Grasse
New production site connects sourcing, transformation, innovation and production, links with Floral Concept and extends local naturals know‑how into Symrise’s global perfumery network.
22 September 2026
Metso secures €40m+ five‑year analyzer LCS deal with South American copper producer
Five‑year outcome‑based analyzer Life Cycle Services contract covering modernization, new analyzers, sampling, spares, digital support and O&M for copper processing.
22 September 2026
Econic launches Recreaire 17RC28 CO2-based ultra-mild surfactant for personal care
Ultra-mild CO2-derived emulsifier with 28% CO2 content and about 25% lower carbon footprint that matches conventional surfactant performance in lotions, creams and haircare.
22 September 2026
Evonik refocuses portfolio and German sites, funds growth via Tailor Made cuts
Aligns businesses by role, assigns roles to six German sites, and shifts investment to Asia/Americas; launches growth projects in Canada and Slovakia, funded by cost cuts.
21 September 2026
Genentech: enicepatide Phase II cuts HbA1c and weight in T2D with overweight/obesity
Once‑weekly dual GLP‑1/GIP enicepatide cut HbA1c up to 2.65% and body weight 15.5% at 48 weeks in Phase II; safety aligned with the incretin class.
21 September 2026
POSCO builds next‑generation galvanized automotive steel plant
KRW 480 billion investment for a 450,000 t/yr continuous galvanizing line at Gwangyang; EAF‑linked lower‑carbon, extra‑wide products and AI/robotics for quality and safety.
21 September 2026
Eli Lilly breaks ground on $6.5B Houston API and advanced therapeutics site
New $6.5B Houston plant will make APIs including Foundayo, create 600+ high-wage jobs, and fund $12.5M for workforce training with San Jacinto College.
21 September 2026
Novo Nordisk: CagriSema outperforms tirzepatide 5 mg for weight loss
CagriSema 1.0/1.0 delivered greater weight loss than tirzepatide 5 mg and 21% vs 2% vs placebo in obesity trial; HbA1c reduction was non‑inferior. FDA decision expected Q4 2026.
21 September 2026
Merck’s KEYTRUDA QLEX approved in Japan for subcutaneous use across all KEYTRUDA indications
First subcutaneous immune‑checkpoint inhibitor in Japan; can be given in as little as one minute and showed comparable exposure and response to IV pembrolizumab in a phase‑3 trial.
21 September 2026
Roche: European Commission approves Susvimo for nAMD
Continuous ranibizumab delivery via the Contivue refillable implant offers an alternative to monthly intravitreal injections, with as few as two treatments per year.
21 September 2026
EWE awards Bilfinger contract for Huntorf hydrogen treatment
Engineering, installation and commissioning of an H2 drying system for a 16 million Nm³ repurposed salt cavern; Bilfinger’s H2Dry debuts commercially; operations targeted 2028.
21 September 2026
BHP and China Baowu renew five-year steel decarbonisation MoU
Partnership will focus on modified blast furnaces, DRI and electric smelting demonstrations using Pilbara iron ore to lower steelmaking emissions.
21 September 2026
Technip Energies to license SABIC CTR® LDPE technology worldwide
Exclusive Licensing Collaboration makes one partner the worldwide licensor of CTR® LDPE technology, formalising long-standing cooperation and leveraging decades of execution expertise.
21 September 2026
Velocys launches AlphaCore 800 microchannel FT reactor
Microchannel FT reactor rated up to 800 bpd (~30 kt/a) per unit, designed to reduce reactor count and support 100+ kt/a SAF and e‑fuel projects.
18 September 2026
Eli Lilly: FDA approves Inluriyo (imlunestrant) plus Verzenio for ER+, HER2–, ESR1‑mutated advanced/metastatic breast cancer
FDA grants full approval to the all‑oral imlunestrant + abemaciclib combination for adults with ER+, HER2–, ESR1‑mutated advanced or metastatic breast cancer after prior endocrine therapy.
18 September 2026
Merck wins CHMP positive opinion for KEYTRUDA plus Padcev in resectable MIBC
CHMP recommends approval after KEYNOTE-B15 showed event-free survival, overall survival and pathologic complete response gains; European Commission decision expected Q4 2026.
18 September 2026
Novo Nordisk’s Sogroya recommended by EMA CHMP for idiopathic short stature in children
Once-weekly somapacitan (Sogroya) receives CHMP positive opinion for children with idiopathic short stature; European Commission decision expected later this year.
18 September 2026
Roche: CHMP recommends Ocrevus for paediatric relapsing MS (age 10+)
CHMP backs ocrelizumab for relapsing MS in patients aged 10 and older after Phase III showed stronger lesion suppression and comparable relapse control versus fingolimod.
18 September 2026
Sinopec: five technical devices picked in NEA sixth major energy equipment batch
Five technologies, including a 10 kW assembled aluminum‑air emergency power unit and a 500 standard m3/h methanol‑to‑hydrogen unit, were among 90 national selections.
17 September 2026
Moeve starts Onuba — 300 MW first phase of Andalusian Green Hydrogen Valley
First phase delivers 300 MW (option +105 MW), ~45,000 tH2/yr, >€1bn phase investment, €304m public support and an expected >8,000 jobs across the value chain.
Next →
